Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis

Last updated: October 20, 2026 4:50 pm

Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.

Source: CNBC

Share This Article

ByThe True Post

The newsroom of The True Post.

Top Stories

Fluorescent reaction maps reveal how catalyst activity changes with operating conditions

Keanu Reeves in Talks to Star in James Wan’s ‘The Gangster, The Cop, The Devil’ at Paramount

Zelenskyy visits Norway amid Trump White House tensions

Stay Connected

Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis

Leave a Reply Cancel reply

Related Stories

Trump envoy warned Greek minister US can bring down ‘any country we want’, report claims

Munich Oktoberfest opens as revellers flock to world’s largest beer festival

Could Lady Gaga be "The Cure" for a Japanese convenience store's labor shortage?

SpaceX stock climbs to highest since June, returning Musk to trillionaire status

From the archives: Eva Marie Saint on why she never "went Hollywood"

Iran-US war latest: Tehran warns it is ready for ‘doomsday’ war as Trump rejects roadmap to end conflict

How to Talk to Your Child About Body Image

WATCH: Biggest moments from the first-ever Banana Ball championship

Sections

The Newsroom